CSRP1 and posterior cortical atrophy: To validate the anti-oncogenic properties of CSRP1 in PCa, we generated PC3/CSRP1 (Fig. 5A), LNCaP-CSRP1 (Fig. 5B) and LNCaP/CSRP1 (Supplementary Fig. 1D) cells.